Hikma Pharmaceuticals PLC (HIK.L)
GBp 1921.0
(-0.05%)
GBp 1921.0
(-0.05%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 4.68 Billion USD | 4.67% |
| 2022 | 4.47 Billion USD | 2.26% |
| 2021 | 4.37 Billion USD | 5.73% |
| 2020 | 4.13 Billion USD | 5.22% |
| 2019 | 3.93 Billion USD | 12.38% |
| 2018 | 3.49 Billion USD | 3.22% |
| 2017 | 3.38 Billion USD | -22.35% |
| 2016 | 4.36 Billion USD | 68.0% |
| 2015 | 2.59 Billion USD | 15.37% |
| 2014 | 2.25 Billion USD | 16.69% |
| 2013 | 1.92 Billion USD | 11.5% |
| 2012 | 1.73 Billion USD | 9.8% |
| 2011 | 1.57 Billion USD | 41.21% |
| 2010 | 1.11 Billion USD | 9.1% |
| 2009 | 1.02 Billion USD | 5.82% |
| 2008 | 966.45 Million USD | 8.1% |
| 2007 | 894.04 Million USD | 83.07% |
| 2006 | 488.35 Million USD | 22.71% |
| 2005 | 397.96 Million USD | 61.46% |
| 2004 | 246.48 Million USD | 109.13% |
| 2003 | 117.86 Million USD | 24.25% |
| 2002 | 94.86 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 4.84 Billion USD | 0.0% |
| 2023 Q2 | 4.61 Billion USD | 0.0% |
| 2023 FY | 4.68 Billion USD | 4.67% |
| 2023 Q4 | 4.68 Billion USD | 0.0% |
| 2022 Q4 | 4.47 Billion USD | 0.0% |
| 2022 FY | 4.47 Billion USD | 2.26% |
| 2022 Q2 | 4.74 Billion USD | 0.0% |
| 2021 FY | 4.37 Billion USD | 5.73% |
| 2021 Q2 | 4.18 Billion USD | 0.0% |
| 2021 Q4 | 4.37 Billion USD | 0.0% |
| 2020 Q2 | 3.97 Billion USD | 0.0% |
| 2020 FY | 4.13 Billion USD | 5.22% |
| 2020 Q4 | 4.13 Billion USD | 0.0% |
| 2019 Q4 | 3.93 Billion USD | 0.0% |
| 2019 Q2 | 3.6 Billion USD | 0.0% |
| 2019 FY | 3.93 Billion USD | 12.38% |
| 2018 Q2 | 3.34 Billion USD | 0.0% |
| 2018 FY | 3.49 Billion USD | 3.22% |
| 2018 Q4 | 3.49 Billion USD | 0.0% |
| 2017 Q2 | 4.39 Billion USD | 0.0% |
| 2017 FY | 3.38 Billion USD | -22.35% |
| 2017 Q4 | 3.38 Billion USD | 0.0% |
| 2016 Q4 | 4.36 Billion USD | 0.0% |
| 2016 FY | 4.36 Billion USD | 68.0% |
| 2016 Q2 | 4.5 Billion USD | 0.0% |
| 2015 FY | 2.59 Billion USD | 15.37% |
| 2015 Q2 | 2.5 Billion USD | 0.0% |
| 2015 Q4 | 2.59 Billion USD | 0.0% |
| 2014 Q2 | 2.06 Billion USD | 0.0% |
| 2014 Q4 | 2.25 Billion USD | 0.0% |
| 2014 FY | 2.25 Billion USD | 16.69% |
| 2013 Q4 | 1.92 Billion USD | 0.0% |
| 2013 Q2 | 1.73 Billion USD | 0.0% |
| 2013 FY | 1.92 Billion USD | 11.5% |
| 2012 Q4 | 1.73 Billion USD | 300.0% |
| 2012 Q3 | 432.52 Million USD | -74.0% |
| 2012 Q2 | 1.66 Billion USD | 284.57% |
| 2012 Q1 | 432.52 Million USD | -72.55% |
| 2012 FY | 1.73 Billion USD | 9.8% |
| 2011 Q1 | 393.9 Million USD | -64.18% |
| 2011 Q3 | 393.9 Million USD | -72.21% |
| 2011 FY | 1.57 Billion USD | 41.21% |
| 2011 Q4 | 1.57 Billion USD | 300.0% |
| 2011 Q2 | 1.41 Billion USD | 259.79% |
| 2010 Q4 | 1.09 Billion USD | 300.0% |
| 2010 Q2 | 1.06 Billion USD | 288.35% |
| 2010 Q1 | 274.95 Million USD | -73.12% |
| 2010 FY | 1.11 Billion USD | 9.1% |
| 2010 Q3 | 274.95 Million USD | -74.25% |
| 2009 Q3 | 255.68 Million USD | -74.53% |
| 2009 FY | 1.02 Billion USD | 5.82% |
| 2009 Q4 | 1.02 Billion USD | 300.0% |
| 2009 Q2 | 1 Billion USD | 292.57% |
| 2009 Q1 | 255.68 Million USD | -73.54% |
| 2008 Q4 | 966.45 Million USD | 300.0% |
| 2008 Q1 | 241.61 Million USD | -72.98% |
| 2008 Q2 | 979.71 Million USD | 305.49% |
| 2008 Q3 | 241.61 Million USD | -75.34% |
| 2008 FY | 966.45 Million USD | 8.1% |
| 2007 Q4 | 894.04 Million USD | 300.0% |
| 2007 Q1 | 223.51 Million USD | -54.23% |
| 2007 FY | 894.04 Million USD | 83.07% |
| 2007 Q2 | 607.13 Million USD | 171.64% |
| 2007 Q3 | 223.51 Million USD | -63.19% |
| 2006 FY | 488.35 Million USD | 22.71% |
| 2006 Q1 | 122.08 Million USD | -69.32% |
| 2006 Q2 | 423.15 Million USD | 246.6% |
| 2006 Q3 | 122.08 Million USD | -71.15% |
| 2006 Q4 | 488.35 Million USD | 300.0% |
| 2005 Q3 | 99.48 Million USD | -66.19% |
| 2005 Q1 | 99.48 Million USD | 61.46% |
| 2005 FY | 397.96 Million USD | 61.46% |
| 2005 Q4 | 397.95 Million USD | 300.0% |
| 2005 Q2 | 294.29 Million USD | 195.8% |
| 2004 FY | 246.48 Million USD | 109.13% |
| 2004 Q4 | 61.61 Million USD | 0.0% |
| 2004 Q3 | 61.61 Million USD | 0.0% |
| 2004 Q1 | 61.61 Million USD | 109.12% |
| 2004 Q2 | 61.61 Million USD | 0.0% |
| 2003 Q2 | 29.46 Million USD | 0.0% |
| 2003 FY | 117.86 Million USD | 24.25% |
| 2003 Q4 | 29.46 Million USD | 0.0% |
| 2003 Q1 | 29.46 Million USD | 24.25% |
| 2003 Q3 | 29.46 Million USD | 0.0% |
| 2002 Q1 | 23.71 Million USD | 0.0% |
| 2002 Q3 | 23.71 Million USD | 0.0% |
| 2002 Q4 | 23.71 Million USD | 0.0% |
| 2002 Q2 | 23.71 Million USD | 0.0% |
| 2002 FY | 94.86 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|